Compare Entegris Inc (ENTG) vs HCA Health Inc (HCA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Entegris Inc vs HCA Health Inc — how do they compare? Entegris Inc trades at $134.14 (market cap $21.12B), while HCA Health Inc trades at $388.84 (market cap $84.04B). The key difference: HCA Health Inc is far larger — about 4× Entegris Inc's market cap, and HCA Health Inc pays the higher dividend (0.82%). Which is the better fit depends on your goals.
| ENTG | HCA | |
|---|---|---|
Market Cap | $21.12B | $84.04B |
Sector | Technology | Health |
52-Week High | $184.00 | $545.13 |
52-Week Low | $68.80 | $334.32 |
Enterprise Value | $24.44B | $132.95B |
Dividend Yield | 0.29% | 0.82% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Entegris (ENTG) trades at $140.63, up 3.2% on the day, with a bearish technical signal and premium valuation metrics. The company reported strong Q1 2026 earnings, beating estimates, and maintains a solid cash flow position. Recent news highlights a quarterly dividend declaration and a non-exclusive cross-licensing agreement for EUV lithography technology.
The outlook is mixed: Wall Street analysts maintain a bullish consensus with a $178.40 price target (26.9% upside), citing AI-driven semiconductor demand as a catalyst. However, risks include elevated valuation multiples, competitive pressures in the semiconductor materials sector, and execution challenges in maintaining recent earnings momentum.
HCA Healthcare (HCA) is trading at $363.60, down 6.95% amid lowered 2026 guidance. The stock shows bearish technical signals but maintains strong fundamentals with consistent revenue growth to $75.6 billion in 2025 and earnings beats in recent quarters. Analyst consensus remains bullish with a $469.40 price target despite recent negative sentiment from payer mix challenges.
The outlook presents a value opportunity given attractive valuation multiples (P/E 13.05, EV/EBITDA 8.48) and dividend yield, though risks include rising uninsured patients and margin compression. Long-term growth drivers include capacity expansion and specialty care investments, but near-term volatility may persist until Q2 earnings clarity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Entegris Inc
Entegris Inc is a supplier of advanced materials and process solutions for the semiconductor and other high-technology industries. The company's reportable segments include Specialty Chemicals & Engineered Materials (SCEM), Microcontamination Control (MC), and Advanced Materials Handling (AMH). The SCEM segment provides high-performance & high-purity process chemistries, gases, & materials, and safe & efficient delivery systems. The Microcontamination Control (MC) segment includes solutions to purify critical liquid chemistries and process gases used in semiconductor manufacturing processes and other high-technology industries. Its geographical segments are Taiwan, North America, South Korea, Japan, China, Europe, and Southeast Asia.
Read more on ENTG →About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →
